Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 16, 2012Current Opinion in Oncology

Interactions between the tumor suppressor p53 and immune responses

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDaniel MenéndezNational Institute of Environmental Health SciencesMSMaria ShatzNational Institute of Environmental Health SciencesMRMichael A. ResnickNational Institute of Environmental Health Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Menéndez et al. (2012) studied this question.

synapsesocial.com/papers/6a8213d96cfba4e31a9fd89fhttps://doi.org/10.1097/cco.0b013e32835b6386
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Natural Innate and Adaptive Immunity to Cancer2011 · 2,122 citations
  2. 2TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer2006 · 492 citations
  3. 3Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma2002 · 155 citations
  4. 4p53 Research: The Past Thirty Years and the Next Thirty Years2010 · 451 citations
  5. 5A transcriptionally active DNA-binding site for human p53 protein complexes.1992 · 721 citations